News

2 Minute Medicine2d

Artificial intelligence-guided ultrasound lacks sufficient accuracy for deep vein thrombosis detection

Curry and colleagues tested an artificial intelligence (AI) software that guided non-radiology specialists in diagnosing ...
2 Minute Medicine1d

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

In this cohort of women living with HIV (WLWH) in Rwanda, there was an increased risk of delivering a low birth weight (LBW) ...
2 Minute Medicine2d

Intensive systolic blood pressure targets may be cost-effective across most measurement error possibilities

In this microsimulation model of patients with high cardiovascular risk, an intensive systolic blood pressure (SBP) target of ...
2 Minute Medicine2d

Clinically significant differences between different blood pressure measurement methods

In this systematic review and meta-analysis, estimated blood pressure was found to vary significantly between different ...
2 Minute Medicine2d

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

Invasive breast cancer recurrence was significantly reduced with extended aromatase inhibitor therapy. 2. No significant ...
2 Minute Medicine6d

Lilly Strikes $1.3 Billion GPCR Drug Discovery Pact with Superluminal

Deal worth up to $1.3 billion brings AI-powered GPCR target discovery into Lilly’s obesity and cardiometabolic pipeline. 2.
2 Minute Medicine3d

GSK and Hengrui Pharma Forge $500 Million China Collaboration

GSK paid $500 million upfront for global development rights to Hengrui’s portfolio of up to 12 early-stage assets. 2. Includes a PDE3/4 inhibitor for COPD plus programs in oncology, respiratory, ...
2minutemedicine.com4d

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

Key Points: 1. Schrödinger discontinued its SGR-2921 CDC7 inhibitor program following two treatment-related deaths in a Phase 1 trial. 2. AML patients showed early signs of benefit, but safety ...